K Brickell D Porter P Thompson
10.1038/sj.bjc.6601137
Br J Cancer
2003 Aug 18;89(4):615-6.
CC BY
https://pubmed.ncbi.nlm.nih.gov/12915866/
Anticonvulsants / adverse effects Antimetabolites, Antineoplastic / adverse effects Deoxycytidine / adverse effects Deoxycytidine / analogs & derivatives Epilepsy, Generalized / drug therapy Fluorouracil / adverse effects Phenytoin / adverse effects
Anticonvulsants / adverse effects Antimetabolites, Antineoplastic / adverse effects Deoxycytidine / adverse effects Deoxycytidine / analogs & derivatives Epilepsy, Generalized / drug therapy Fluorouracil / adverse effects Phenytoin / adverse effects Case Reports Adenocarcinoma / drug therapy Administration, Oral Aged Anticonvulsants / therapeutic use Antimetabolites, Antineoplastic / therapeutic use Breast Neoplasms / drug therapy Capecitabine Colonic Neoplasms / drug therapy Deoxycytidine / therapeutic use Drug Interactions Epilepsy, Generalized / pathology Female Fluorouracil / therapeutic use Humans Male Middle Aged Phenytoin / therapeutic use Anticonvulsants Antimetabolites, Antineoplastic Deoxycytidine Phenytoin Capecitabine Fluorouracil
PMC2376914
12915866
Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports
2003